Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single‐institution retrospective study
- 5 August 2022
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 44 (11) , 2465-2472
Abstract
Background: Survival outcomes in recurrent head and neck squamous cell carcinoma (HNSCC) are poor. This study aimed to compare survival outcomes between salvage surgery and immunotherapy in patients with recurrent advanced HNSCC. Methods: Patients with advanced stage (stage III or IV) recurrent HNSCC following treatment with platinum‐based chemotherapy were included. Survival was estimated using the Kaplan–Meier method, and Cox regression was used for multivariate logistic regression. Results: Two‐year overall survival after salvage surgery was 68.6% and after immunotherapy patients was 24.6%. Multivariate logistic regression showed that salvage surgery was associated with improved survival without statistical significance (hazard ratio [HR] 0.12, p = 0.25). Subgroup analysis of patients with oral cavity/oropharyngeal cancer noted improved survival with salvage surgery over immunotherapy (HR 0.006, p = 0.01) and decreased survival with neutrophil‐to‐lymphocyte ratio (NLR) > 5 (HR 6.4, p = 0.02). Conclusion: Our retrospective single‐institutional data suggest that resectable advanced stage recurrent HNSCC may have improved survival with salvage surgery in appropriately selected patients, but larger prospective studies are required.Keywords
This publication has 20 references indexed in Scilit:
- Failure pattern and salvage treatment after radical treatment of head and neck cancerActa Oncologica, 2016
- Salvage surgery for locally recurrent oropharyngeal cancerHead & Neck, 2015
- Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapyAuris Nasus Larynx, 2015
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancerBiomarkers, 2010
- The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynxCancer, 2009
- Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas—Stratification for postsalvage survivalHead & Neck, 2009
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Results of Surgical Salvage After Failure of Definitive Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic LarynxJAMA Otolaryngology–Head & Neck Surgery, 2006
- Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neckSeminars in Radiation Oncology, 2004